We have 256 products in: Biochemicals >> Research Area >> Parkinson's Disease

Parkinson's Disease beginning with A - C

A - C   D - I   J - N   O - S   T - Z   

Code

Name

Details

 Image Abreview Publication 

  

A-412997 dihydrochloride 

Highly selective D4 agonist

Purity: > 98%

 
 
 
 
  

Acetylcholine chloride 

Endogenous neurotransmitter active at acetylcholine receptors

 
 
 
 
  

6,7-ADTN hydrobromide 

Dopamine agonist

Purity: > 99%

 
Specific publication references
 
 
 
  

Alprenolol Fluorescent ligand (Red) 

Fluorescent β2 adrenoceptor antagonist

Purity: > 97%

Images
 
 
 
 
  

AMN082 dihydrochloride 

mGlu7 agonist

Purity: > 99%

 
Specific publication references
 
 
 
  

(R,S)-AMPA 

AMPA agonist

Purity: > 99%

Images
 
Specific publication references
 
 
 
  

(S)-AMPA 

AMPA agonist

Purity: > 98%

Images
 
Specific publication references
 
 
 
  

(±)-Anatoxin A fumarate 

Potent nicotinic agonist

Purity: > 98%

 
Specific publication references
 
 
 
  

Aniracetam 

AMPA receptor potentiator

Purity: > 99%

 
 
 
 
  

DL-AP4 

Broad spectrum glutamate antagonist

Purity: > 99%

 
 
 
 
  

L-AP4 

Selective group III mGlu agonist

Purity: > 99%

 
Specific publication references
 
 
 
  

DL-AP4 sodium salt 

Broad spectrum glutamate antagonist; water soluble

Purity: > 99%

 
 
 
 
  

D-AP5 

NMDA glutamate site antagonist

Purity: > 99%

Images
 
Specific publication references
 
 
 
  

DL-AP5 

NMDA glutamate site antagonist

Purity: > 99%

 
Specific publication references
 
 
 
  

DL-AP5 sodium salt 

NMDA glutamate site antagonist. Water soluble form.

Purity: > 99%

 
Specific publication references
 
 
 
  

Aripiprazole 

Partial dopamine D2 agonist

Purity: > 99%

 
 
 
 
  

Asenapine maleate 

Multiple receptor antagonist. Antipsychotic agent.

Purity: > 99%

 
 
 
 
  

(R,S)-Atenolol 

β1 Adrenoceptor antagonist

Purity: > 99%

 
 
 
 
  

(S)-(-)-Atenolol 

Selective β1 adrenoceptor antagonist

Purity: > 98%

 
 
 
 
  

Atipamezole hydrochloride 

Selective α2 adrenoceptor antagonist

Purity: > 99%

 
 
 
 
  

(±)-Bisoprolol hemifumarate 

Selective β1 antagonist

Purity: > 99%

 
 
 
 
  

BMY 7378 dihydrochloride 

5-HT1A partial agonist. α adrenoceptor antagonist.

Purity: > 99%

 
 
 
 
  

Bopindolol malonate 

Non-selective, potent adrenoceptor antagonist

Purity: > 99%

 
 
 
 
  

BRL 15572 monohydrochloride 

Selective 5-HT1D receptor antagonist

Purity: > 98%

 
 
 
 
  

BRL 54443 maleate salt 

Selective, high affinity 5-ht1e and 5-HT1F receptor agonist

Purity: > 99%

 
 
 
 
  

Bromocriptine mesylate 

Potent, selective D2-like dopamine receptor agonist

Purity: > 99%

 
 
 
 
  

α-Bungarotoxin 

Subtype-selective α7 nAChR antagonist

Purity: > 99%

 
Specific publication references
 
 
 
  

Bupranolol 

Potent non-selective β adrenoceptor antagonist

Purity: > 99%

 
 
 
 
  

Bupropion hydrochloride 

Non-selective DAT/NET inhibitor

Purity: > 98%

 
 
 
 
  

Buspirone hydrochloride 

5HT1A agonist. Anxiolytic.

Purity: > 99%

 
 
 
 
  

Cabergoline 

D2-like receptor agonist

Purity: > 99%

Images
 
 
 
 
  

Carvedilol 

Potent β and α1 adrenoceptor antagonist

Purity: > 99%

 
 
 
 
  

CDPPB 

PAM for mGlu5. Active in vivo.

Purity: > 98%

 
 
 
 
  

CGP 37849 

Competitive NMDA antagonist

Purity: > 99%

 
Specific publication references
 
 
 
  

CGP 39551 

Competitive NMDA antagonist

Purity: > 99%

 
Specific publication references
 
 
 
  

7-Chlorokynurenic acid 

NMDA receptor glycine site antagonist

Purity: > 99%

Images
 
 
 
 
  

7-Chlorokynurenic acid sodium salt 

NMDA receptor glycine site antagonist; water soluble

Purity: > 99%

Images
 
Specific publication references
 
 
 
  

(S)-5-Chlorowillardiine 

AMPA / kainate agonist

Purity: > 98%

Images
 
Specific publication references
 
 
 
  

(±)-Chlorpheniramine maleate 

Potent H1 antagonist and SNRI

Purity: > 99%

 
 
 
 
  

(R,S)-CHPG 

Selective mGlu5 agonist

Purity: > 98%

Images
 
Specific publication references
 
 
 
  

(R,S)-CHPG sodium salt 

mGlu5 agonist; water soluble

Purity: > 99%

 
Specific publication references
 
 
 
  

Cimaterol 

β-adrenoceptor agonist

Purity: > 99%

 
 
 
 
  

Cisapride 

5-HT4 receptor agonist. hERG blocker.

Purity: > 99%

 
 
 
 
  

Citalopram 

5-HT reuptake inhibitor

Purity: > 98%

 
Specific publication references
 
 
 
  

Clozapine 

Atypical antipsychotic

Purity: > 98%

 
Specific publication references
 
 
 
  

CNQX 

AMPA / kainate antagonist

Purity: > 99%

Images
 
Specific publication references
 
 
 
  

CNQX disodium salt 

AMPA / kainate antagonist; water soluble

Purity: > 99%

Images
 
Specific publication references
 
 
 
  

CP 94253 dihydrochloride 

Highly potent, selective 5-HT1B agonist

Purity: > 98%

 
 
 
 
  

CPCCOEt 

Selective, non-competitive mGlu1 antagonist

Purity: > 98%

 
Specific publication references
 
 
 
  

(R)-CPP 

Potent NMDA antagonist

 
Specific publication references
 
 
 
  

(R,S)-CPP 

Potent NMDA antagonist

 
 
 
 
  

(R)-CPPene (SDZ EAA 494) 

Potent competitive NMDA antagonist

Purity: > 98%

 
 
 
 
  

CPPG 

Potent group II/III metabotropic glutamate receptor antagonist

Purity: > 99%

 
 
 
 
  

D-Cycloserine 

NMDA glycine site agonist

Purity: > 99%

 
 
 
 
  

Cyclothiazide 

AMPA receptor desensitisation inhibitor

Purity: > 98%

 
Specific publication references
 
 
 
  

Cyproheptadine hydrochloride 

Potent H1 and 5-HT2B antagonist. Non-selective receptor antagonist.

Purity: > 99%

 
 
 
 
  

(-)-Cytisine 

Potent, selective nAChR agonist

Purity: > 99%

 
Specific publication references
 
 
 

Back to top

A - C   D - I   J - N   O - S   T - Z   

Back to top